These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Stromal PD-L1-Positive Regulatory T cells and PD-1-Positive CD8-Positive T cells Define the Response of Different Subsets of Non-Small Cell Lung Cancer to PD-1/PD-L1 Blockade Immunotherapy. Wu SP; Liao RQ; Tu HY; Wang WJ; Dong ZY; Huang SM; Guo WB; Gou LY; Sun HW; Zhang Q; Xie Z; Yan LX; Su J; Yang JJ; Zhong WZ; Zhang XC; Wu YL J Thorac Oncol; 2018 Apr; 13(4):521-532. PubMed ID: 29269008 [TBL] [Abstract][Full Text] [Related]
4. Characterization of the cytolytic activity of CD4+ and CD8+ tumor-infiltrating lymphocytes in human renal cell carcinoma. Finke JH; Rayman P; Alexander J; Edinger M; Tubbs RR; Connelly R; Pontes E; Bukowski R Cancer Res; 1990 Apr; 50(8):2363-70. PubMed ID: 2107973 [TBL] [Abstract][Full Text] [Related]
5. Increased populations of regulatory T cells in peripheral blood and tumor-infiltrating lymphocytes in patients with gastric and esophageal cancers. Ichihara F; Kono K; Takahashi A; Kawaida H; Sugai H; Fujii H Clin Cancer Res; 2003 Oct; 9(12):4404-8. PubMed ID: 14555512 [TBL] [Abstract][Full Text] [Related]
6. Phenotyping of lymphocytes expressing regulatory and effector markers in infiltrating ductal carcinoma of the breast. Leong PP; Mohammad R; Ibrahim N; Ithnin H; Abdullah M; Davis WC; Seow HF Immunol Lett; 2006 Feb; 102(2):229-36. PubMed ID: 16246429 [TBL] [Abstract][Full Text] [Related]
7. Phenotypic analysis of tumor-infiltrating lymphocytes in hepatocellular carcinoma. Chen CH; Lee HS; Huang GT; Yang PM; Yu WY; Cheng KC; Lee PH; Jeng YM; Chen DS; Sheu JC Hepatogastroenterology; 2007; 54(77):1529-33. PubMed ID: 17708291 [TBL] [Abstract][Full Text] [Related]
8. The CD4/CD8 ratio of tumor-infiltrating lymphocytes at the tumor-host interface has prognostic value in triple-negative breast cancer. Wang K; Shen T; Siegal GP; Wei S Hum Pathol; 2017 Nov; 69():110-117. PubMed ID: 28993275 [TBL] [Abstract][Full Text] [Related]
10. Significance of Tumor-Infiltrating Lymphocytes and the Expression of Topoisomerase IIα in the Prediction of the Clinical Outcome of Patients with Triple-Negative Breast Cancer after Taxane-Anthracycline-Based Neoadjuvant Chemotherapy. Rao N; Qiu J; Wu J; Zeng H; Su F; Qiu K; Wu J; Yao H Chemotherapy; 2017; 62(4):246-255. PubMed ID: 28472798 [TBL] [Abstract][Full Text] [Related]
11. Importance of CD45RO+ tumor-infiltrating lymphocytes in post-operative survival of breast cancer patients. Ahmadvand S; Faghih Z; Montazer M; Safaei A; Mokhtari M; Jafari P; Talei AR; Tahmasebi S; Ghaderi A Cell Oncol (Dordr); 2019 Jun; 42(3):343-356. PubMed ID: 30825183 [TBL] [Abstract][Full Text] [Related]
12. Cytokine gene therapy of gliomas: induction of reactive CD4+ T cells by interleukin-4-transfected 9L gliosarcoma is essential for protective immunity. Giezeman-Smits KM; Okada H; Brissette-Storkus CS; Villa LA; Attanucci J; Lotze MT; Pollack IF; Bozik ME; Chambers WH Cancer Res; 2000 May; 60(9):2449-57. PubMed ID: 10811123 [TBL] [Abstract][Full Text] [Related]
13. Concomitant Expression of CD39, CD69, and CD103 Identifies Antitumor CD8+ T cells in Breast Cancer Implications for Adoptive Cell Therapy. Gattas GI; Noël G; López F; González F; Prieto-Hinojosa A; Nava-Rivera LE; Willard-Gallo K; Argüello JR Curr Pharm Biotechnol; 2023 Sep; ():. PubMed ID: 37680154 [TBL] [Abstract][Full Text] [Related]
14. Functional Heterogeneity of CD4 Oja AE; Piet B; van der Zwan D; Blaauwgeers H; Mensink M; de Kivit S; Borst J; Nolte MA; van Lier RAW; Stark R; Hombrink P Front Immunol; 2018; 9():2654. PubMed ID: 30505306 [TBL] [Abstract][Full Text] [Related]
15. Immunophenotyping of patients with oral squamous cell carcinoma in peripheral blood and associated tumor tissue. Grimm M; Feyen O; Hofmann H; Teriete P; Biegner T; Munz A; Reinert S Tumour Biol; 2016 Mar; 37(3):3807-16. PubMed ID: 26474587 [TBL] [Abstract][Full Text] [Related]
16. Computerised counting of tumour infiltrating lymphocytes in 90 breast cancer specimens. Marsigliante S; Biscozzo L; Marra A; Nicolardi G; Leo G; Lobreglio GB; Storelli C Cancer Lett; 1999 May; 139(1):33-41. PubMed ID: 10408906 [TBL] [Abstract][Full Text] [Related]
17. The predictive and prognostic value of Foxp3+/CD25+ regulatory T cells and PD-L1 expression in triple negative breast cancer. Zhang L; Wang XI; Ding J; Sun Q; Zhang S Ann Diagn Pathol; 2019 Jun; 40():143-151. PubMed ID: 31096176 [TBL] [Abstract][Full Text] [Related]
18. Compromised lymphocytes infiltrate hepatocellular carcinoma: the role of T-regulatory cells. Unitt E; Rushbrook SM; Marshall A; Davies S; Gibbs P; Morris LS; Coleman N; Alexander GJ Hepatology; 2005 Apr; 41(4):722-30. PubMed ID: 15791620 [TBL] [Abstract][Full Text] [Related]
19. Flow cytometric analysis of tumour infiltrating lymphocyte activation and tumour cell MHC class I and II expression in breast cancer patients. Whitford P; George WD; Campbell AM Cancer Lett; 1992 Jan; 61(2):157-64. PubMed ID: 1730139 [TBL] [Abstract][Full Text] [Related]
20. Expansion of Tumor-reactive T Cells From Patients With Pancreatic Cancer. Meng Q; Liu Z; Rangelova E; Poiret T; Ambati A; Rane L; Xie S; Verbeke C; Dodoo E; Del Chiaro M; Löhr M; Segersvärd R; Maeurer MJ J Immunother; 2016; 39(2):81-9. PubMed ID: 26849077 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]